New study from Access to Medicine Foundation analyses 10 years of data on pharma companies and access to medicine
In a new report the Access to Medicine Foundation shows where pharmaceutical companies have made progress in the past ten years when it comes to access to medicine. It analyses companies’ performances in 106 low- and middle-income countries – home to 83% of all people alive today.
It finds clear evidence of progress, most notably in R&D, and in how companies approach access. A few companies are carrying the greater part of the load. Overall, companies’ activity concentrates on a few diseases and countries.
“Compared with ten years ago, pharmaceutical companies are taking seriously the problems people face in low- and middle-income countries when accessing healthcare. The situation is still fragile – a retreat by one company, or a drop in healthcare investments, will jeopardise the progress made so far.” Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation.
To read the full announcement, click here.
